Human non-small cell lung cancer (NSCLC) cell lines with inactivated LKB1 and KRAS mutations are sensitive to MEK inhibition

C.Mahoney; B.Choudhury; H.Davies; G.Bignell; M.Stratton; A.Futreal

首页> 外文期刊>European Journal of Cancer Supplements >Human non-small cell lung cancer (NSCLC) cell lines with inactivated LKB1 and KRAS mutations are sensitive to MEK inhibition

【24h】

Human non-small cell lung cancer (NSCLC) cell lines with inactivated LKB1 and KRAS mutations are sensitive to MEK inhibition

机译：具有灭活的LKB1和KRAS突变的人非小细胞肺癌（NSCLC）细胞系对MEK抑制敏感

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第9期|共2页
作者
C.Mahoney; B.Choudhury; H.Davies; G.Bignell; M.Stratton; A.Futreal;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Human non-small cell lung cancer (NSCLC) cell lines with inactivated LKB1 and KRAS mutations are sensitive to MEK inhibition [J] . C.Mahoney, B.Choudhury, H.Davies, European Journal of Cancer Supplements . 2008,第9期

机译：具有灭活的LKB1和KRAS突变的人非小细胞肺癌（NSCLC）细胞系对MEK抑制敏感
2. Inhibition of epigenetic modifiers in non-small lung cancer cell lines with loss of function mutations in SWI/SNF chromatin remodeling genes: a tool for selective radiosensitization of BRG1 mutant NSCLC cell lines [J] . Zernickel E., Sak A., Niedermaier B., Strahlentherapie und Onkologie . 2018,第Suppla1期

机译：在SWI / SNF染色质重塑基因中抑制非小肺癌细胞系中的表观遗传调节剂，其功能突变丧失：BRG1突变NSCLC细胞系的选择性放射敏化工具
3. Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach [J] . Elisa Caiola, Francesca Falcetta, Silvia Giordano, Journal of experimental & clinical cancer research : . 2018,第1期

机译：非小细胞肺癌细胞中同时发生的KRAS突变/ LKB1缺失导致代谢活动增强，易受热量限制：体外整合多水平方法
4. EFFECTS OF CARVACROL ON A HUMAN NON-SMALL CELL LUNG CANCER (NSCLC) CELL LTNE, A549 [C] . A.Tansu Koparal, Melih Zeytinoglu Annual Meeting of the Japanese Association for Animal Cell Technology . 2003

机译：Carvacrol对人非小细胞肺癌（NSCLC）细胞LTNE，A549的影响
5. 4HPR-X radiation mechanisms of interactions in non-small cell lung cancer (NSCLC) cells in vitro. [D] . Nasca, Melita Maria. 2002

机译：4HPR-X辐射在非小细胞肺癌（NSCLC）细胞中相互作用的体外机制。
6. KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition [O] . H Hamidi, M Lu, K Chau, 2014

机译：KRAS突变亚型和拷贝数预测人胰腺癌细胞系对MEK抑制的体外反应
7. Impact on KRAS-subtypes and TP53 mutations on the prognostic value of KRAS/KEAP1 comutations in non-small cell lung cancer (NSCLC) [O] . M. Scheffler, R. Frank, M.A. Ihle, 2019

机译：对克拉斯 - 亚型和TP53突变对非小细胞肺癌（NSCLC）的克拉斯/ keap1性关系的影响

Human non-small cell lung cancer (NSCLC) cell lines with inactivated LKB1 and KRAS mutations are sensitive to MEK inhibition

著录项

相似文献

相关主题

期刊订阅